Masimo‘s patented autonomous drug delivery system uses patient monitor data to automatically administer necessary medication when specific criteria are met. An emergency button allows manual intervention. The system can deliver drugs like opioid antagonists, hypotensive drugs, or anti-arrhythmia medications based on physiological parameters. GlobalData’s report on Masimo gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Masimo, Medical data analysis was a key innovation area identified from patents. Masimo's grant share as of January 2024 was 59%. Grant share is based on the ratio of number of grants to total number of patents.
Automated first responder system for drug delivery
A recently granted patent (Publication Number: US11883190B2) discloses an automated first responder system designed to monitor and respond to physiological parameters of a patient in need of urgent medical intervention. The system includes a patient monitor that analyzes physiological data to determine if it aligns with a diagnostic model, triggering an alarm if necessary. In the event of no response within a set time frame, an autonomous delivery device administers a substance to the patient. Subsequent analysis of the patient's condition may prompt a second alarm indicating the need for additional substance, with strict criteria for administration based on life-threatening parameter values.
The system's diagnostic models cover conditions such as opioid overdose, hypovolemia, and sepsis, each with specific physiological indicators and corresponding substances for treatment. The hardware processor can also incorporate patient data, such as lab tests, comorbidities, or treatment history, to refine the response strategy. With configurable time frames for intervention and the ability to adjust thresholds dynamically based on individual patient data, the system aims to provide timely and tailored emergency care. Additionally, the system's automated features ensure a rapid response in critical situations, potentially saving lives by delivering necessary treatment promptly and efficiently.
To know more about GlobalData’s detailed insights on Masimo, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
